News
Please enjoy the latest industry news aggregated from top Life Sciences sources including BioPharma Dive, FierceBiotech and STAT.
- STAT Plus: Lawmaker chastises Pfizer for reverting to price hikes next month
- Pfizer to add 100 oncology R&D jobs, cut others amid restructure
- STAT Plus: Pennsylvania auditor recommends new laws to crack down on PBM contracts for Medicaid
- Former Merck, Purdue Pharma Exec Timney Named Medicines Company CEO
- Merck promotes oncology, vaccine executives to replace Adam Schechter in commercial rejig
- Pear’s digital treatment for opioid abuse gets FDA nod
- Pear opioid-oriented prescription digital therapeutic gets FDA nod
- Boehringer Ingelheim chops 295 jobs in France but vows $380M in animal health investments
- Merck’s Ebola vaccine has ‘major impact,’ but U.S. should help as outbreak worsens: experts
- China’s Zhejiang Huahai lambasted in FDA warning letter for putting profits ahead of safety
- Black Diamond debuts with $20M, mission to drug unexplored oncogenes
- FDA clears Pear’s smartphone app therapy for opioid use disorder
- As competition heats up, U.S. prices for Remicade and biosims slip: analyst
- STAT Plus: Pharmalittle: What two former Alexion execs are doing now; pharma pushes back on Trump price plan
- Merck shakes up C-suite as Schechter departs